- Home
- WMS vs MEDP Comparison
WMS vs MEDP Comparison
Compare WMS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMS
- MEDP
- Stock Information
- Founded
- WMS 1966
- MEDP 1992
- Country
- WMS United States
- MEDP United States
- Employees
- WMS N/A
- MEDP N/A
- Industry
- WMS Containers/Packaging
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- WMS Consumer Discretionary
- MEDP Health Care
- Exchange
- WMS Nasdaq
- MEDP Nasdaq
- Market Cap
- WMS 9.5B
- MEDP 10.5B
- IPO Year
- WMS 2014
- MEDP 2016
- Fundamental
- Price
- WMS $125.52
- MEDP $337.35
- Analyst Decision
- WMS Strong Buy
- MEDP Buy
- Analyst Count
- WMS 8
- MEDP 10
- Target Price
- WMS $166.88
- MEDP $389.00
- AVG Volume (30 Days)
- WMS 636.6K
- MEDP 235.7K
- Earning Date
- WMS 02-06-2025
- MEDP 02-10-2025
- Dividend Yield
- WMS 0.51%
- MEDP N/A
- EPS Growth
- WMS 6.40
- MEDP 33.84
- EPS
- WMS 6.28
- MEDP 11.42
- Revenue
- WMS $2,914,153,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- WMS $2.98
- MEDP $13.95
- Revenue Next Year
- WMS $6.28
- MEDP $5.49
- P/E Ratio
- WMS $19.98
- MEDP $29.53
- Revenue Growth
- WMS 2.94
- MEDP 16.24
- 52 Week Low
- WMS $110.75
- MEDP $286.76
- 52 Week High
- WMS $184.27
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- WMS 59.28
- MEDP 47.28
- Support Level
- WMS $110.75
- MEDP $327.00
- Resistance Level
- WMS $118.07
- MEDP $359.63
- Average True Range (ATR)
- WMS 3.28
- MEDP 9.20
- MACD
- WMS 1.97
- MEDP -0.72
- Stochastic Oscillator
- WMS 91.09
- MEDP 31.73
About WMS Advanced Drainage Systems Inc.
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe; Infiltrator; International and Allied Products and Other. It generates maximum revenue from the Pipe segment. The company serves Agriculture; Aviation and Military; Mining; Residential; Transportation; Healthcare and Education and others.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.